Kathryn Alsop

5PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 06, 2026
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Feb 01, 2024
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.

Kate Gersekowski, Renhua Na, Kathryn Alsop

|Mar 09, 2022
TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.

Rachel Delahunty, Linh Nguyen, Stuart Craig

Pageof 1